within Pharmacolibrary.Drugs.ATC.A;

model A02BX15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 30 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Teprenone is a gastric mucosal protective agent used in the treatment of gastric ulcers, gastritis, and other gastric mucosal disorders. It is not FDA-approved in the United States but is used in some Asian countries. It works mainly by enhancing endogenous prostaglandin production, protecting the gastric mucosa.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with detailed model parameters (such as clearance, volume of distribution, ka) for teprenone have been located in the accessible scientific literature as of 2024. The parameters below are rough estimates based on general pharmacokinetic principles for compounds of similar molecular weight and oral use.</p><h4>References</h4><ol><li><p>Nishizawa, Y, et al., &amp; Kinoshita, K (1987). Identification of urinary and microsomal metabolites of geranylgeranylacetone in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 17(5) 575–584. DOI:<a href=&quot;https://doi.org/10.3109/00498258709043964&quot;>10.3109/00498258709043964</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3604262/&quot;>https://pubmed.ncbi.nlm.nih.gov/3604262</a></p></li><li><p>Song, Q, et al., &amp; Qi, X (2008). HPLC-APCI-MS for the determination of vitamin K(1) in human plasma: method and clinical application. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 875(2) 541–545. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2008.10.009&quot;>10.1016/j.jchromb.2008.10.009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18952509/&quot;>https://pubmed.ncbi.nlm.nih.gov/18952509</a></p></li><li><p>Adachi, H, et al., &amp; Araki, E (2010). An acylic polyisoprenoid derivative, geranylgeranylacetone protects against visceral adiposity and insulin resistance in high-fat-fed mice. <i>American journal of physiology. Endocrinology and metabolism</i> 299(5) E764–E771. DOI:<a href=&quot;https://doi.org/10.1152/ajpendo.00075.2010&quot;>10.1152/ajpendo.00075.2010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20716696/&quot;>https://pubmed.ncbi.nlm.nih.gov/20716696</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BX15;
